ct

Current cover

Recent in Regulatory (page 1 of 38)

FDA Alert: New J&J Baby Powder Recall

According to the FDA, a test sample from one lot was found to contain chrysotile fibers, a type of asbestos. As such, Oct. 18, 2019, Johnson & Johnson voluntarily recalled the product.

A Closer Look at Cosmetic Claims

Claims cannot be considered legal unless they are truthful, and truthfulness requires evidence, which needs to be honest. Theresa Callaghan, Ph.D., explores these laws and the relationship between claims and consumers in a new book.

DSM Seeks FDA Sunscreen Monograph Approval of Bemotrizinol

DSM believes it is important for consumers in the USA to benefit from the efficacy and aesthetics that modern filters such as BEMT can provide. As such, the company is pushing for Monograph status.

Could the FDA Sunscreen Monograph See a New Addition?

It's been decades since the FDA's OTC Sunscreen Monograph welcomed a new addition; back then, it was avobenzone. Now, another could be joining the ranks.

EPA Eyes 20 Chemicals for High Priority Risk Evaluation, ACC Responds

"EPA is providing a 90-day comment period during which interested persons may provide comments on the proposed designations of High-Priority Substances for risk evaluation." Read on to learn more.

Words from Wiechers: High-resolution Resolutions

As we use terms that have scientific meaning, marketing meaning and common meaning, we will always be confused as to which meaning is in use. Read on to see what O'Lenick and Wiechers have to say about this.

Illinois Bans Animal Testing for Cosmetics

Illinois has become the third state in the U.S. to prohibit the sale of cosmetics that have been tested on animals. Read on for details and exceptions.

CVS Removes Controversial Sunscreen Chemicals from Store-brand Products

CVS store-brand sunscreen products will no longer contain certain sunscreen ingredients thought to damage marine ecosystems.

PCPC Sounds Off on US FDA's Sunscreen Proposals

Industry organizations worry that consumers may be deterred from using sunscreens—causing unintended negative health effects—due to the U.S. Food and Drug Administration's recent sunscreen proposals.

FDA Warns CBD Company Making Unsubstantiated Marketing Claims

The agency has issued a warning letter to Curaleaf Inc., for illegally selling unapproved products containing cannabidiol (CBD) online. The company is accused of making unsubstantiated claims that the products treat cancer, Alzheimer’s disease and opioid withdrawal, among other conditions or diseases.

Phthalates Flagged for Endocrine Disruption

Having already made the REACh list of chemicals requiring authorization, four phthalates are now recommended by European legislators to be flagged as endocrine disruptors.

The INCI Name Game: A Commentary

When misinformed groups play in a technical space, nontechnically trained regulators make irrelevant rules, and INCI names are generalized and misused, you have the perfect storm for consumer confusion.

Can't find what you're looking for? Try searching, or looking through past issues.